Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 48
Filter
Add more filters










Publication year range
1.
FEMS Microbiol Lett ; 176(1): 45-50, 1999 Jul 01.
Article in English | MEDLINE | ID: mdl-10418130

ABSTRACT

Subtilin is an antimicrobial peptide of the lantibiotic family that is produced by Gram-positive Bacillus subtilis, and its biosynthesis involves expression of presubtilin which consists of a leader segment and a mature segment. The leader segment is unlike a typical sec-type general secretion signal, and its ability to mediate translocation through a non-sec pathway has been previously studied by fusing the subtilin leader to an alkaline phosphatase reporter and expressing it in B. subtilis 168 [Izaguirre, G. and Hansen, J. N. (1997) Appl. Environ. Microbiol. 63, 3965-3971]. In this work, we have expressed the same subtilin leader-AP fusion in Gram-negative Escherichia coli, and found that the AP polypeptide is translocated into the periplasmic compartment and assembles into an enzymatically active form. The subtilin leader segment was not cleaved from this enzymatically active AP, which remained associated with the membrane. Conversion of the cells to spheroplasts followed by treatment with proteinase K showed that about 50% of the bound AP was sufficiently exposed on the surface of the spheroplasts to be inactivated by proteolytic cleavage.


Subject(s)
Alkaline Phosphatase/metabolism , Anti-Bacterial Agents/metabolism , Bacterial Proteins , Peptides , Protein Precursors/metabolism , Protein Sorting Signals/metabolism , Bacillus subtilis/genetics , Bacillus subtilis/metabolism , Bacteriocins , Blotting, Western , Cloning, Molecular/methods , Escherichia coli , Plasmids/metabolism , Protein Sorting Signals/biosynthesis , Time Factors
2.
J Biol Chem ; 273(36): 23134-42, 1998 Sep 04.
Article in English | MEDLINE | ID: mdl-9722542

ABSTRACT

An antimicrobial peptide produced by Bacillus subtilis 168 was isolated and characterized. It was named sublancin 168, and its behavior during Edman sequence analysis and its NMR spectrum suggested that sublancin is a dehydroalanine-containing lantibiotic. A hybridization probe based on the peptide sequence was used to clone the presublancin gene, which encoded a 56-residue polypeptide consisting of a 19-residue leader segment and a 37-residue mature segment. The mature segment contained one serine, one threonine, and five cysteine residues. Alkylation of mature sublancin showed no free sulfhydryl groups, suggesting that one sulfydryl had formed a beta-methyllanthionine bridge with a dehydrobutyrine derived by posttranslational modification of threonine; with the other four cysteines forming two disulfide bridges. It is unprecedented for a lantibiotic to contain a disulfide bridge. The sublancin leader was similar to known type AII lantibiotics, containing a double-glycine motif that is typically recognized by dual-function transporters. A protein encoded immediately downstream from the sublancin gene possessed features of a dual-function ABC transporter with a proteolytic domain and an ATP-binding domain. The antimicrobial activity spectrum of sublancin was like other lantibiotics, inhibiting Gram-positive bacteria but not Gram-negative bacteria; and like the lantibiotics nisin and subtilin in its ability to inhibit both bacterial spore outgrowth and vegetative growth. Sublancin is an extraordinarily stable lantibiotic, showing no degradation or inactivation after being stored in aqueous solution at room temperature for 2 years. The fact that sublancin is a natural product of B. subtilis 168, for which a great deal of genetic information is available, including the entire sequence of its genome, suggests that sublancin will be an especially good model for studying the potential of lantibiotics as sources of novel biomaterials.


Subject(s)
ATP-Binding Cassette Transporters/genetics , Anti-Bacterial Agents/chemical synthesis , Bacillus subtilis/genetics , Genes, Bacterial , Peptides , Protein Precursors/genetics , Amino Acid Sequence , Anti-Bacterial Agents/chemistry , Bacterial Proteins/genetics , Bacteriocins , Base Sequence , Biological Transport , Cloning, Molecular , Disulfides/chemistry , Glycopeptides , Microbial Sensitivity Tests , Molecular Sequence Data , Nuclear Magnetic Resonance, Biomolecular , Protons , Sequence Analysis, DNA , Sequence Homology, Amino Acid
3.
Appl Environ Microbiol ; 63(10): 3965-71, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9327561

ABSTRACT

The subtilin leader segment of presubtilin was fused to alkaline phosphatase (AP), which was used as a reporter polypeptide to study the role of the subtilin leader segment in posttranslational modifications during the conversion of presubtilin to subtilin and in the translocation of presubtilin from the cytoplasm of Bacillus subtilis 168 to the extracellular medium. It was observed that the subtilin leader segment could be utilized by a wild-type transporter, but secretion was enhanced if the subtilin transporter was available. The subtilin leader was not cleaved away from the AP component of the precursor until the precursor had been transported to the cell wall, and none of the AP was released into the medium until after cleavage had occurred. The role of SpaT, which is an ABC transporter that has been implicated in subtilin secretion, was explored by making a large in-frame deletion from the central region of SpaT and observing the effect on translocation of the AP reporter. Instead of having an effect on translocation, the deletion disrupted proteolytic cleavage of the subtilin leader segment and release of the AP reporter into the medium. The AP that was secreted by means of the subtilin leader segment had not undergone any posttranslational modifications, as assessed by amino acid composition analysis and enzymatic activity analysis.


Subject(s)
Alkaline Phosphatase/metabolism , Anti-Bacterial Agents/metabolism , Bacillus subtilis/metabolism , Bacterial Proteins , Peptides , Alkaline Phosphatase/genetics , Amino Acid Sequence , Artificial Gene Fusion , Bacillus subtilis/genetics , Bacillus subtilis/growth & development , Bacteriocins , Gene Deletion , Gene Expression , Genes, Bacterial , Genes, Reporter , Membrane Proteins/genetics , Molecular Sequence Data , Protein Precursors/metabolism , Protein Processing, Post-Translational , Protein Sorting Signals/genetics , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism
4.
J Bacteriol ; 177(23): 6874-80, 1995 Dec.
Article in English | MEDLINE | ID: mdl-7592481

ABSTRACT

The ability to respond to osmotic stress by osmoregulation is common to virtually all living cells. Gram-negative bacteria such as Escherichia coli and Salmonella typhimurium can achieve osmotolerance by import of osmoprotectants such as proline and glycine betaine by an import system encoded in an operon called proU with genes for proteins ProV, ProW, and ProX. In this report, we describe the discovery of a proU-type locus in the gram-positive bacterium Bacillus subtilis. It contains four open reading frames (ProV, ProW, ProX, and ProZ) with homology to the gram-negative ProU proteins, with the B. subtilis ProV, ProW, and ProX proteins having sequence homologies of 35, 29, and 17%, respectively, to the E. coli proteins. The B. subtilis ProZ protein is similar to the ProW protein but is smaller and, accordingly, may fulfill a novel role in osmoprotection. The B. subtilis proU locus was discovered while exploring the chromosomal sequence upstream from the spa operon in B. subtilis LH45, which is a subtilin-producing mutant of B. subtilis 168. B. subtilis LH45 had been previously constructed by transformation of strain 168 with linear DNA from B. subtilis ATCC 6633 (W. Liu and J. N. Hansen, J. Bacteriol. 173:7387-7390, 1991). Hybridization experiments showed that LH45 resulted from recombination in a region of homology in the proV gene, so that the proU locus in LH45 is a chimera between strains 168 and 6633. Despite being a chimera, this proU locus was fully functional in its ability to confer osmotolerance when glycine betaine was available in the medium. Conversely, a mutant (LH45 deltaproU) in which most of the proU locus had been deleted grew poorly at high osmolarity in the presence of glycine betaine. We conclude that the proU-like locus in B. subtilis LH45 is a gram-positive counterpart of the proU locus in gram-negative bacteria and probably evolved prior to the evolutionary split of prokaryotes into gram-positive and gram-negative forms.


Subject(s)
Amino Acid Transport Systems , Anti-Bacterial Agents/biosynthesis , Bacillus subtilis/genetics , Bacterial Proteins/genetics , Carrier Proteins/genetics , Operon , Peptides , Water-Electrolyte Balance/genetics , Adaptation, Physiological/genetics , Amino Acid Sequence , Bacillus subtilis/growth & development , Bacillus subtilis/physiology , Bacteriocins , Base Sequence , Betaine/metabolism , Escherichia coli/genetics , Molecular Sequence Data , Open Reading Frames , Osmotic Pressure , Proline/metabolism , Recombination, Genetic , Sequence Deletion , Sequence Homology, Amino Acid
5.
J Biol Chem ; 270(40): 23533-9, 1995 Oct 06.
Article in English | MEDLINE | ID: mdl-7559517

ABSTRACT

Biosynthesis of lantibiotics such as nisin and subtilin involves post-translational modifications, including dehydration of serines and threonines, formation of thioether cross-linkages, translocation, cleavage of a leader sequence, and release into the medium. We have studied the cellular machinery that performs the modifications by constructing and expressing nisin-subtilin chimeric prepeptides in a strain of Bacillus subtilis 168 that possesses all of the cellular machinery for making subtilin except for the presubtilin gene. The chimeras consisted of a normal subtilin leader region (SL), fused to nisin-subtilin chimeric structural regions, one of which was SL-Nis1-11-Sub12-32, in which the N-terminal portion of the structural region was derived from nisin, and the C-terminal portion derived from subtilin. This chimera was accurately and efficiently converted to the corresponding mature lantibiotic, as established by reverse phase high performance liquid chromatography profiles, proton NMR spectroscopy, mass spectral analysis, and biological activity. A succinylated form of the chimera was also produced. Another chimera was in the reverse sense, with subtilin sequence at the N terminus and nisin sequence at the C terminus of the structural region (SL-Sub1-11-Nis12-34). It was processed into a heterogeneous mixture of products, none of which had the characteristics of a correctly processed polypeptide, but did contain a minor component that was active, with a specific activity that considerably exceeded nisin itself. These results, together with results published earlier, establish that processing requires specific recognition between the prelantibiotic peptide and the processing machinery, and in order for the processing to occur correctly, there must be an appropriate combination of the N-terminal part of the leader region and the C-terminal part of the structural region of the prepeptide.


Subject(s)
Anti-Bacterial Agents/chemistry , Bacterial Proteins , Nisin/chemistry , Peptides , Amino Acid Sequence , Anti-Bacterial Agents/pharmacology , Bacillus subtilis/genetics , Bacillus subtilis/growth & development , Bacillus subtilis/metabolism , Bacteriocins , Base Sequence , Chromatography, High Pressure Liquid , DNA, Bacterial/genetics , DNA, Recombinant/genetics , Genes, Bacterial , Magnetic Resonance Spectroscopy , Mass Spectrometry , Molecular Sequence Data , Molecular Structure , Nisin/genetics , Nisin/pharmacology , Protein Sorting Signals/chemistry , Protein Sorting Signals/genetics , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/pharmacology , Structure-Activity Relationship
6.
Crit Rev Food Sci Nutr ; 34(1): 69-93, 1994.
Article in English | MEDLINE | ID: mdl-8142045

ABSTRACT

Nisin is a ribosomally synthesized peptide that has broad-spectrum antibacterial activity, including activity against many bacteria that are food-spoilage pathogens. Nisin is produced as a fermentation product of a food-grade bacterium, and the safety and efficacy of nisin as a food preservative have resulted in its widespread use throughout the world, including the U.S. Nisin is a member of the class of antimicrobial substances known as lantibiotics, so called because they contain the unusual amino acid lanthionine. Lantibiotics, in general, have considerable promise as food preservatives, although only nisin has been sufficiently well characterized to be used for this purpose. As the number of known natural lantibiotics has increased and their useful characteristics have been explored, it has become desirable to synthesize structural analogs of nisin and other lantibiotics that do not occur naturally. The fact that lantibiotics are gene-encoded peptides synthesized by transcription and translation allows structural variants to be generated by mutagenesis. This review focuses on the progress that has been made in the construction and biological expression of genetically engineered nisin structural analogs. For example, a host-vector pair has been engineered that permits the construction of mutants of the structural gene for subtilin, which is a naturally occurring structural analog of nisin. The vector is designed in such a way that the mutant gene can be substituted for the natural subtilin gene in the chromosome of Bacillus subtilis, which in turn directs the transcription, translation, posttranslational modifications, and secretion of the mature form of the structural analog. Several structural analogs have been constructed, and their properties have provided insight into some of the structure-function relationships in lantibiotics, as well as their mechanism of antimicrobial action. These advances are assessed together with potential problems in the future development of nisin analogs as valuable new food preservatives.


Subject(s)
Bacterial Proteins , Food Preservatives , Nisin , Peptides , Amino Acid Sequence , Anti-Bacterial Agents , Bacillus subtilis/genetics , Bacteria/drug effects , Bacteriocins , Drug Design , Fermentation , Molecular Sequence Data , Mutagenesis, Site-Directed , Nisin/chemistry , Nisin/genetics , Nisin/pharmacology , Recombinant Proteins
7.
Appl Environ Microbiol ; 59(2): 648-51, 1993 Feb.
Article in English | MEDLINE | ID: mdl-8434932

ABSTRACT

Subtilin is a ribosomally synthesized antimicrobial peptide that contains several unusual amino acids as a result of posttranslational modifications. Site-directed mutagenesis was employed to construct a structural variant of subtilin in which the unusual dehydroalanine (Dha) residue at position 5 was changed to alanine. Proton nuclear magnetic resonance spectroscopy, amino acid composition, and N-terminal sequence analysis established that the mutation did not disrupt posttranslational processing of the precursor peptide. This mutant subtilin was devoid of antimicrobial activity as assessed by its lack of inhibitory effects on outgrowth of Bacillus cereus T spores. However, this same mutant subtilin was fully active with respect to its ability to induce lysis of vegetative B. cereus T cells. Because an intact Dha-5 residue is required in the one instance but not in the other, it was concluded that the molecular mechanism by which subtilin inhibits (without lysis) spore outgrowth is not the same as the mechanism by which it inhibits (with lysis) vegetative cells.


Subject(s)
Anti-Bacterial Agents , Anti-Bacterial Agents/pharmacology , Bacillus cereus/drug effects , Bacterial Proteins , Peptides , Spores, Bacterial/drug effects , Amino Acid Sequence , Anti-Bacterial Agents/chemistry , Bacillus cereus/growth & development , Bacteriocins , Molecular Sequence Data , Mutagenesis, Site-Directed , Peptides, Cyclic/chemistry , Peptides, Cyclic/genetics , Peptides, Cyclic/pharmacology , Spores, Bacterial/growth & development
8.
Annu Rev Microbiol ; 47: 535-64, 1993.
Article in English | MEDLINE | ID: mdl-8257108

ABSTRACT

Peptides that have antimicrobial activity are synthesized by many prokaryotic and eukaryotic organisms. Antimicrobial peptides commonly contain unusual amino acids that contribute to their properties and functions. Although bacteria synthesize most of these peptides by nonribosomal mechanisms, this review focuses on those that are synthesized by pathways that involve posttranslational modification of ribosomally synthesized precursor peptides. A particularly interesting class of these antimicrobial peptides is the lantibiotics, of which nisin and subtilin are the longest-known examples, although nearly a dozen new lantibiotics have been discovered in recent years. The fact that the lantibiotic structures are derived from gene-encoded peptides means that structural analogs of natural lantibiotics can be constructed by mutagenesis of their structural genes. Recent advances in our understanding of the molecular genetics of lantibiotics has made the construction of novel lantibiotics with enhanced chemical and antimicrobial properties possible. This review describes these advances and proposes future trends of research, as well as potential application of engineered lantibiotics, in the context of the general field of antimicrobial peptides.


Subject(s)
Anti-Bacterial Agents/biosynthesis , Protein Processing, Post-Translational , Amino Acid Sequence , Bacteria/genetics , Bacteria/metabolism , Molecular Sequence Data
9.
J Biol Chem ; 267(35): 25078-85, 1992 Dec 15.
Article in English | MEDLINE | ID: mdl-1460009

ABSTRACT

Subtilin and nisin are gene-encoded antibiotic peptides that are ribosomally synthesized by Bacillus subtilis and Lactococcus lactis, respectively. Gene-encoded antibiotics are unique in that their structures can be manipulated by mutagenesis of their structural genes. Although subtilin and nisin share considerable structural homology, subtilin has a greater tendency than nisin to undergo spontaneous inactivation. This inactivation is a accompanied by chemical modification of the dehydroalanine at position 5 (DHA5) with a kinetic first-order t1/2 of 0.8 days. It was hypothesized that the R group carboxyl of Glu4 in subtilin participates in the chemical modification of the adjacent DHA5. Noting that nisin has Ile at position 4, site-directed mutagenesis was used to change Glu4 of subtilin to Ile, in order to eliminate this carboxyl-group participation. The DHA5 of this mutant subtilin (E4I-subtilin) underwent modification with a t1/2 of 48 days, which is 57-fold slower than natural subtilin, and the rate of loss of biological activity dropped by a like amount. These results suggest that an intact DHA5 is critical for subtilin activity against bacterial spore outgrowth. A double mutant of subtilin, in which the DHA5 residue of E4I-subtilin was mutated to Ala was devoid of detectable inhibition against spore outgrowth. The specific activity of E4I-subtilin was 3-4-fold higher than natural subtilin, suggesting that an increase in the hydrophobicity of the N-terminal end of the molecule enhances activity. These are the first mutants of subtilin that have been reported, and E4I-subtilin is the first example of any lantibiotic whose properties have been improved by mutagenesis. In order to carry out the mutagenesis, a host-vector pair was constructed that permits a deletion replacement in which the natural subtilin gene is replaced by the mutant gene at the normal location in the chromosome. This maintains normal gene dosage and regulatory responses, as well as eliminates ambiguities caused by expression of the normal and mutant genes in the same cell.


Subject(s)
Bacillus subtilis/genetics , Mutagenesis, Site-Directed , Protein Conformation , Subtilisins/chemistry , Subtilisins/pharmacology , Amino Acid Sequence , Base Sequence , Chromosomes, Bacterial , Cloning, Molecular , Escherichia coli/genetics , Genes, Bacterial , Kinetics , Magnetic Resonance Spectroscopy , Molecular Sequence Data , Operon , Plasmids , Recombinant Proteins/chemistry , Recombinant Proteins/pharmacology , Restriction Mapping , Subtilisins/genetics , Terminator Regions, Genetic
10.
J Bacteriol ; 174(20): 6699-702, 1992 Oct.
Article in English | MEDLINE | ID: mdl-1400221

ABSTRACT

An 851-residue open reading frame (ORF) called SpaE has been discovered in the subtilin (spa) operon. Interruption of this ORF with a chloramphenicol acetyltransferase gene destroys the ability of Bacillus subtilis LH45 delta c (a derivative of B. subtilis 168) to produce subtilin, which is an antimicrobial peptide belonging to the class of ribosomally synthesized peptide antibiotics called lantibiotics. SpaE shows strong homology to NisB, which is in the nisin (nis) operon in Lactococcus lactis ATCC 11454. Despite the strong sequence homology between SpaE and NisB, the spaE and nisB genes occupy very different locations in their respective operons, indicating that they have been evolving separately for a long time. Primer extension analysis was employed to identify a promoter upstream from the spaE gene, which appears to define the 5' end of the spa operon, which contains four other ORFs (Y. J. Chung, M. T. Steen, and J. N. Hansen, J. Bacteriol. 174:1417-1422, 1992).


Subject(s)
Anti-Bacterial Agents , Bacillus subtilis/genetics , Bacterial Proteins/genetics , Membrane Proteins , Operon/genetics , Peptides , Promoter Regions, Genetic/genetics , Amino Acid Sequence , Bacterial Proteins/chemistry , Bacteriocins , Base Sequence , Molecular Sequence Data , Peptides, Cyclic/genetics , Restriction Mapping , Sequence Homology, Amino Acid
11.
J Bacteriol ; 174(4): 1417-22, 1992 Feb.
Article in English | MEDLINE | ID: mdl-1735728

ABSTRACT

Sequence analysis upstream from the subtilin structural gene (spaS) in Bacillus subtilis ATCC 6633 revealed several open reading frames, SpaB, SpaC, and SpaD. SpaB, consisting of 599 amino acid residues, shows excellent homology with a variety of membrane translocator proteins, such as HlyB from Escherichia coli and some mammalian multidrug resistance proteins. When the spaB gene was interrupted by integration of a chloramphenicol acetyltransferase gene, the ability of the cell to produce subtilin, as determined by a halo assay, was lost. The homology of SpaB to translocator proteins, including transmembrane and ATP-binding regions, suggests that SpaB may play a role in subtilin secretion. The SpaB open reading frame overlaps with another open reading frame called SpaC, and the possibility that the SpaB and SpaC proteins become fused by frameshifting is considered. Regions of homology between SpaD (177 residues) and HlyD were also found, suggesting that SpaD may participate with SpaB in translocation of subtilin through the membrane. Although no readily interpretable homologies to SpaC (442 residues) were found, its sequence suggests that it is membrane associated. The absence of rho-independent transcription terminators between these open reading frames suggests that they are all part of the same operon.


Subject(s)
Anti-Bacterial Agents , Bacillus subtilis/genetics , Bacterial Proteins , Carrier Proteins/genetics , Genes, Overlapping/genetics , Peptides , Amino Acid Sequence , Bacillus subtilis/metabolism , Bacteriocins , Base Sequence , Carrier Proteins/metabolism , Hemolysin Proteins/metabolism , Molecular Sequence Data , Operon/genetics , Peptides, Cyclic/genetics , Restriction Mapping , Sequence Homology, Nucleic Acid
12.
J Bacteriol ; 173(22): 7387-90, 1991 Nov.
Article in English | MEDLINE | ID: mdl-1938928

ABSTRACT

Subtilin is a ribosomally synthesized peptide antibiotic produced by Bacillus subtilis ATCC 6633. B. subtilis 168 was converted to a subtilin producer by competence transformation with chromosomal DNA from B. subtilis ATCC 6633. A chloramphenicol acetyltransferase gene was inserted next to the subtilin structural gene as a selectable marker. The genes that conferred subtilin production were derived from a 40-kb region of the B. subtilis ATCC 6633 chromosome that had flanking homologies to the B. subtilis 168 chromosome. The subtilin produced by the mutant was identical to natural subtilin in its biological activity, chromatographic behavior, amino acid composition, and N-terminal amino acid sequence.


Subject(s)
Bacillus subtilis/genetics , Genes, Bacterial , Subtilisins/genetics , Transformation, Bacterial , Amino Acid Sequence , Bacillus subtilis/enzymology , DNA, Bacterial/genetics , DNA, Bacterial/isolation & purification , Genetic Markers , Molecular Sequence Data , Plasmids , Restriction Mapping , Subtilisins/biosynthesis
13.
J Biol Chem ; 266(24): 16078-84, 1991 Aug 25.
Article in English | MEDLINE | ID: mdl-1831453

ABSTRACT

To understand the molecular structure of the vacuolar H(+)-translocating ATPase from plants, cDNAs encoding the N,N'-dicyclohexylcarbodiimide-binding 16-kDa proteolipid from oat (Avena sativa L. var. Lang) have been obtained. A synthetic oligonucleotide corresponding to a region of the bovine proteolipid cDNA (Mandel, M., Moriyama, Y., Hulmes, J.D., Pan, Y.-C.E., Nelson, H., and Nelson, N. (1988) Proc. Natl. Acad. Sci. U.S.A. 85, 5521-5524) was used to screen an oat cDNA library constructed in lambda gt11. The nucleotide sequences of several positive clones (VATP-P1, clones 12, 54, 93) demonstrated the presence of a small multigene family. The four clones showed extensive divergence in their codon usage and their 3'-untranslated regions; however, the deduced amino acid sequences of the proteins were 97-99% identical. These clones encoded the proteolipid subunit as one of them (clone 12) expressed a fusion protein that reacted with an antibody to the 16-kDa proteolipid. The open reading frame of one cDNA clone (VATP-P1) predicted a polypeptide of 165 amino acids with a molecular mass of 16,641. Based on hydropathy plots, a molecule with four membrane-spanning domains was predicted, in which domain IV was especially conserved among different species. This domain showed 80% identity in nucleotide or amino acid sequences between the oat and the bovine proteolipids and contained a glutamate residue that is the putative N,N'-dicyclohexylcarbodiimide-binding residue. The presence of a small multigene family of the 16-kDa proteolipid was confirmed by Southern blot analysis showing that several distinct restriction fragments of oat nuclear DNA hybridized with the VATP-P1 cDNA.


Subject(s)
DNA/genetics , Proteolipids/genetics , Proton-Translocating ATPases/genetics , Vacuoles/enzymology , Amino Acid Sequence , Base Sequence , Cloning, Molecular , Molecular Sequence Data , Multigene Family , Nucleic Acid Hybridization , Open Reading Frames , Plants/enzymology , Plasmids , Sequence Homology, Nucleic Acid
14.
Appl Environ Microbiol ; 57(4): 1181-8, 1991 Apr.
Article in English | MEDLINE | ID: mdl-1905517

ABSTRACT

The location and organization of the nisin locus in Lactococcus lactis ATCC 11454 were studied. Primer extension of in vivo mRNA transcripts of the gene that encodes the nisin prepropeptide sequence indicated the presence of a promoter at least 4 kb upstream from the nisin gene and that the mRNA has several processing sites. Restriction fragment patterns using rare-cutting enzymes, orthogonal pulsed-field clamped homogeneous electric field (CHEF) agarose gel electrophoresis, and hybridization with nisin gene probes showed that the nisin prepropeptide gene was located on a megabase-size restriction fragment, which was taken as proof of a chromosomal location. This is contrary to earlier reports, which had indicated that genes for nisin production were located on plasmids. There was no evidence of more than one chromosomal location or more than one copy of the nisin gene. The restriction patterns indicated that the size of the L. lactis genome is about 2,500 kb. The previously observed (G. W. Buchman, S. Banerjee, and J. N. Hansen, J. Biol. Chem. 263: 16260-16266, 1988) downstream open reading frame (ORF) was fully sequenced to reveal an 851-amino-acid coding region, an upstream putative mRNA processing site, and a putative rho-independent terminator. The ORF was analyzed for secondary structural features, and the sequence data bases were searched for homologies. The ORF contained many amphipathic helices, a C-terminal transmembrane helix, and homologies to some membrane-associated proteins. It lacked an N-terminal membrane insertion sequence and accordingly appears to be associated with, and anchored to, the cytoplasmic side of the membrane. An additional ORF that possessed a ribosome-binding sequence and tandem promoters, indicating the beginning of a new operon, was identified still farther downstream. The results were consistent with the nisin gene being part of a polycistronic operon with a size greater than 8.5 kb.


Subject(s)
Lactococcus lactis/genetics , Nisin/genetics , Operon , Amino Acid Sequence , Base Sequence , Chromosomes, Bacterial , DNA, Bacterial , Molecular Sequence Data , Nucleic Acid Conformation , Open Reading Frames , Restriction Mapping , Transcription, Genetic
15.
Appl Environ Microbiol ; 56(8): 2551-8, 1990 Aug.
Article in English | MEDLINE | ID: mdl-2119570

ABSTRACT

Nisin is a small gene-encoded antimicrobial protein produced by Lactococcus lactis that contains unusual dehydroalanine and dehydrobutyrine residues. The reactivity of these residues toward nucleophiles was explored by reacting nisin with a variety of mercaptans. The kinetics of reaction with 2-mercaptoethane-sulfonate and thioglycolate indicated that the reaction pathway includes a binding step. Reaction of nisin at high pH resulted in the formation of multimeric products, apparently as a result of intramolecular and intermolecular reactions between nucleophilic groups and the dehydro residues. One of the nucleophiles had a pKa of about 9.8. The unique vinyl protons of the dehydro residues that give readily identifiable proton nuclear magnetic resonances were used to observe the addition of nucleophiles to the dehydro moiety. After reaction with nucleophiles, nisin lost its antibiotic activity and no longer showed the dehydro resonances, indicating that the dehydro groups had been modified. The effect of pH on the solubility of nisin was determined; the solubility was quite high at low pH (57 mg/ml at pH 2) and was much lower at high pH (0.25 mg/ml at pH 8 to 12), as measured before significant pH-induced chemical modification had occurred. High-performance liquid chromatography on a C18 column was an effective technique for separating unmodified nisin from its reaction products. The cyanogen bromide cleavage products of nisin were about 90% less active toward inhibition of bacterial spore outgrowth than was native nisin. These results are consistent with earlier observations, which suggested that the dehydro residues of nisin have a role in the mechanism of antibiotic action, in which they act as electrophilic Michael acceptors toward nucleophiles in the cellular target.


Subject(s)
Nisin/isolation & purification , Amino Acid Sequence , Cyanogen Bromide , Drug Stability , Hydrogen-Ion Concentration , Lactococcus lactis/analysis , Magnetic Resonance Spectroscopy , Molecular Sequence Data , Molecular Structure , Nisin/pharmacology , Peptide Fragments/isolation & purification , Peptide Fragments/pharmacology , Solubility , Spores, Bacterial/drug effects , Sulfhydryl Compounds
16.
Virus Genes ; 4(1): 41-52, 1990 Jun.
Article in English | MEDLINE | ID: mdl-1697436

ABSTRACT

The cucumber mosaic virus (CMV) satellites D- and S-CARNA 5 (CARNA 5 = Cucumber mosaic virus-Associated RNA 5), their full-length cDNA clone transcripts, and DNA clone transcripts of their open reading frames (ORFs) were used as mRNAs in the wheat-germ in-vitro translation system. Natural D-CARNA 5 yielded an anomalously large polypeptide, while transcripts made from cDNA clones of D-CARNA 5 or its first ORF had no mRNA activity. Transcripts made from the second major ORF in D-CARNA 5 yielded a smaller product, consistent with its size. Natural S-CARNA 5 and its cDNA clone transcripts both yielded the two polypeptides previously reported, while transcripts of its only major ORF yielded exclusively the smaller of the two products. The potential for an alternate initiation codon, 36 nucleotides upstream, being the source of the larger of the two polypeptides was tested. The differences in the translational properties of D- and S-CARNA 5 were related to the predicted secondary structures of the first 55 nucleotides in these CARNA 5 sequence variants. The calculated free energies of the predicted hairpins correlated inversely with their in-vitro translational activities.


Subject(s)
DNA, Viral/analysis , Genetic Variation , Mosaic Viruses/genetics , Protein Biosynthesis , RNA, Viral/analysis , RNA/analysis , Base Sequence , Cloning, Molecular , Escherichia coli/genetics , Molecular Sequence Data , Nucleic Acid Conformation , RNA, Satellite
17.
Ugeskr Laeger ; 151(40): 2565-9, 1989 Oct 02.
Article in Danish | MEDLINE | ID: mdl-2683281

ABSTRACT

This investigation includes 17,187 patients in 417 hospitals in 16 countries admitted within 24 hours of the commencement of symptoms of acute myocardial infarction (AMI). The patients were allotted at random to the following treatments 1) intravenous infusion of 1.5 million International Units streptokinase (SK) during one hour, 2) 160 mg acetyl salicylic acid (ASA) daily for 30 days, 3) both SK and ASA and 4) placebo treatment only. The five-week cardiovascular mortality was reduced by 25% following infusion of streptokinase from 12.0% to 9.2% and by 23% during ASA treatment from 11.8% to 9.4%. The combination of SK and ASA resulted in 42% reduction in the cardiovascular mortality after five weeks compared with the placebo. The effect of SK was greatest if treatment was instituted within six hours but effects were obtained after all of the first 24 hours. The preliminary results show that the reduction in mortality obtained by both SK and ASA appears to continue during the subsequent one to two years. SK treatment resulted in haemorrhage requiring treatment in 0.5% as compared with 0.2% in the placebo group, more cases of proved cerebral haemorrhage, 0.1% as compared with 0.0%, but fewer cases of cerebral apoplexy, 0.7% as compared with 0.8%. It is concluded that thrombolysis with SK combined with prophylaxis of repeated thrombosis with ASA is the indicated treatment in cases of AMI and less than 6-24 hours duration.


Subject(s)
Aspirin/therapeutic use , Myocardial Infarction/mortality , Streptokinase/therapeutic use , Thrombosis/prevention & control , Aged , Clinical Trials as Topic , Drug Combinations , Female , Humans , Male , Middle Aged , Multicenter Studies as Topic , Myocardial Infarction/complications , Random Allocation
18.
J Biol Chem ; 263(31): 16260-6, 1988 Nov 05.
Article in English | MEDLINE | ID: mdl-3141403

ABSTRACT

We have cloned and sequenced a gene (spaN) from Streptococcus lactis ATCC 11454 which encodes the peptide precursor of the small protein antibiotic nisin. The encoded precursor is 57 amino acids long, with a 23-residue leader region and a 34-residue structural region. The structural region contains serines, threonines, and cysteines at exactly the positions required to give mature nisin by a series of post-translational modifications involving dehydration of serines and threonines to dehydro forms, and cross-linking with cysteine residues. S1 mapping revealed a 267-nucleotide transcript of the nisin gene that is expressed during vegetative growth and stationary phase. It has a half-life of 7-10 min. The absence of an identifiable promoter or rho-independent terminator and the detection of two different 5'-ends of the transcript suggested it is a processing product from a larger RNA. This may represent a polycistronic mRNA which may also encode proteins involved in processing the nisin precursor peptide. Open reading frames were found in regions flanking the nisin gene. The one downstream had a ribosome binding site and appeared to be transcribed by read-through from the nisin gene. The one upstream had significant homology to a putative transposase from the Escherichia coli IS2 insertion element. Comparison of gene sequence homologies between nisin and the other lanthionine antibiotics, subtilin and epidermin, indicated that they all evolved from a common ancestor. Corresponding leader peptide sequences showed mediocre amino acid homology, but nearly perfect hydropathic homologies, suggesting a common function. It is proposed that this function includes recognition signals or other information required for post-translational processing.


Subject(s)
Genes, Bacterial , Genes , Lactococcus lactis/genetics , Nisin/genetics , Amino Acid Sequence , Base Sequence , Blotting, Northern , Molecular Sequence Data , Protein Conformation , Sequence Homology, Nucleic Acid , Transcription, Genetic
19.
J Biol Chem ; 263(28): 14485-90, 1988 Oct 05.
Article in English | MEDLINE | ID: mdl-3139657

ABSTRACT

This is part of a series of two papers on gene regulation in Bacillus subtilis rRNA-tRNA operons that contain large clusters of tRNA genes. The preceding paper (Vold, B.S., Okamoto, K., Murphy, B.J., and Green, C.J. (1988) J. Biol. Chem. 263, 14480-14484) investigates the rrnB operon containing 21 tRNA genes, and this paper investigates a B. subtilis rRNA-tRNA operon containing 16 tRNA genes and a minor 5 S rRNA. Hybridization studies suggest this minor 5 S rRNA occurs as a single copy in the B. subtilis 168 genome. S1 nuclease mapping indicates that this minor 5 S rRNA gene has its own promoter. No promoters have been found immediately 5' to any of the major 5 S rRNA species in B. subtilis rRNA operons. S1 mapping of the spacer region between the 23 S and minor 5 S rRNA revealed that the maturation of the 23 S rRNA in this operon may arise from an unusual processing mechanism. S1 nuclease mapping experiments suggest the existence of a promoter element immediately upstream of the last gene, for tRNA(Leu CAA), in the operon. A precursor leucine tRNA resulting from transcription of this last tRNA gene was observed in Northern hybridizations, and the amounts of this precursor increased during sporulation. A single terminator-like element is located just upstream of this last tRNA gene; however, S1 nuclease mapping experiments suggest that some read-through transcription occurs. Thus, all 16 tRNA genes are under control of the upstream 16 S rRNA promoters and the minor 5 S rRNA promoter. However, the last tRNA gene is primarily under the control of its own unique promoter.


Subject(s)
Bacillus subtilis/genetics , DNA, Ribosomal/genetics , Genes, Bacterial , Operon , RNA, Ribosomal/genetics , RNA, Transfer/genetics , Transcription, Genetic , Base Sequence , Gene Expression Regulation , Molecular Sequence Data , Nucleic Acid Conformation , Nucleotide Mapping
20.
Mol Biol Evol ; 5(5): 500-11, 1988 Sep.
Article in English | MEDLINE | ID: mdl-3143045

ABSTRACT

The immunoglobulin kappa light-chain constant region gene (C kappa) has been cloned and sequenced from five wild mouse species. Analysis of these data has permitted an assessment of single-copy gene evolution during a limited time period as defined by the genus Mus. Sequence conservation was found to be as high (or higher) in the 5' and enhancer regions as in the coding region. The pattern of substitutions throughout these genes suggests that parallel evolution has occurred frequently and that substitutions at replacement sites have not decreased significantly, owing to saturation during this period of approximately 10 Myr. Phylogenetic relationships have been determined among these wild species as well as among members of the genus Rattus.


Subject(s)
Biological Evolution , Genes, Immunoglobulin , Immunoglobulin Constant Regions/genetics , Immunoglobulin kappa-Chains/genetics , Muridae/genetics , Animals , Base Sequence , Cloning, Molecular , DNA/genetics , Enhancer Elements, Genetic , Molecular Sequence Data , Phylogeny , Rats , Repetitive Sequences, Nucleic Acid , Selection, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...